Bayer dosed with heavy demand for €1.3bn hybrid as call nears
Bayer, the German pharmaceutical company, has issued a €1.3bn 60 year non-call 7.5 year hybrid bond, as its hybrid issued in 2005 approaches its first call date.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
